UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D. C. 20549

^{______________}

FORM 8-K

^{______________}

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)    August 23, 2005

^{______________}

Cord Blood America, Inc.

(Exact name of registrant as specified in charter)

^{______________}

Florida	000-50746	65-1078768
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

9000 W. Sunset Boulevard, Suite 400, West Hollywood, CA  90069

(Address of principal executive offices)

(310) 432-4090

(Registrant’s Telephone Number, including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

---

ITEM 2.02

Results of Operations and Financial Condition

On August 23, 2005, Cord Blood America issued a press release reporting financial results for the six months ended June 30, 2005. A copy of the press release is attached hereto as Exhibit 99.21 and the information therein is incorporated herein by reference

ITEM 9.01

Financial Statements and Exhibits

(c)

Exhibits

99.21

Press Release dated August 23, 2005

2

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	CORD BLOOD AMERICA, INC.
	By:	/s/ SANDRA D. SMITH
		Sandra D. Smith,
		Chief Financial Officer

Date:    August 23, 2005

3

---

Exhibit Index

Exhibit Number		Exhibit
99.21		Press Release dated August 23, 2005